216 0

Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2–IIA cervical cancer?

Title
Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2–IIA cervical cancer?
Author
배종운
Keywords
Cervical cancer; Laparoscopy; Radical hysterectomy; Survival
Issue Date
2012-06
Publisher
Elsevier Science INC
Citation
Gynecologic Oncology, 2012, 127(1), P.102-106
Abstract
Objectives. To determine if laparoscopic radical hysterectomy (LRH) can be substituted for radical abdominal hysterectomy for women with International Federation of Gynecology and Obstetrics (FIGO) stage IA2-IIA cervical cancer. Methods. We retrospectively reviewed the medical records of cervical cancer patients who underwent LRH with laparoscopic pelvic lymphadenectomy (LPL) and/or laparoscopic para-aortic lymphadenectomy (LPAL) from March 2003 to December 2011. Results. Of 118 enrolled patients, six were in FIGO stage IA2, 66 were in 1B1, 41 were in IB2, one was in IIA1, and four were in IIA2. The median operating time, perioperative hemoglobin change, the number of harvested pelvic and para-aortic lymph nodes were 270 min (range, 120-495), 1.7 g/dL (range, 0.1-5), 26 (range, 9-55), and 7 (range, 1-39), respectively. There was no unplanned conversion to laparotomy. Intra- and postoperative complications occurred in 16 (13.5%) and 8 (6.7%) patients, respectively. In a median follow-up of 31 months (range, 1-89), 5-year recurrence-free and overall survival rates were 90% and 89%, respectively. Univariate analysis showed that cervical stromal invasion (P=0.023) and lymph node metastasis (P=0.018) affected survival rate. Cox-proportional hazards regression analysis showed that lymph node metastasis was the only independent factor for poor prognosis (hazard ratio =7.0, P=0.022). Conclusions. LRH with LPL and/or LPAL in women with stage IA2-IIA cervical cancer is safe and feasible in terms of survival and morbidity. Our data suggest the need for larger prospective trials which could support this approach as a new standard of care for stage IA2-IIA cervical cancer. (C) 2012 Elsevier Inc. All rights reserved.
URI
http://www.gynecologiconcology-online.net/article/S0090-8258(12)00441-6/fulltexthttp://hdl.handle.net/20.500.11754/67364
ISSN
0090-8258
DOI
10.1016/j.ygyno.2012.06.003
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE